N@N

DOO, MLNX, SCR, FOLD, SCOR, KKR Are Seasonally Ripe To Go Up In the Next Five Weeks

^{Published on 2012-06-28 04:02:07 - WOPRAI}
 

June 28, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of WISDOMTREE INTL DVD EX-FIN (NYSE:DOO), MELLANOX TECHNOLOGIES LTD (NASDAQ:MLNX), SIMCERE PHARMACEUTICAL-ADR (NYSE:SCR), AMICUS THERAPEUTICS INC (NASDAQ:FOLD), COMSCORE INC (NASDAQ:SCOR), KKR & CO LP (NYSE:KKR) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  DOO     WISDOMTREE INTL DVD EX-FIN       3.27%            66.67% (4 of 6)      Thursday, July 19th 2012
  MLNX    MELLANOX TECHNOLOGIES LTD        7.20%            100.00% (5 of 5)     Thursday, July 19th 2012
  SCR     SIMCERE PHARMACEUTICAL-ADR       4.56%            100.00% (5 of 5)     Friday, July 13th 2012
  FOLD    AMICUS THERAPEUTICS INC          17.10%           100.00% (5 of 5)     Friday, July 20th 2012
  SCOR    COMSCORE INC                     4.27%            100.00% (5 of 5)     Tuesday, July 17th 2012
  KKR     KKR & CO LP                      12.78%           100.00% (5 of 5)     Friday, July 27th 2012

MELLANOX TECHNOLOGIES LTD (NASDAQ:MLNX) - Mellanox Technologies, Ltd., a fabless semiconductor company, engages in the design, development, marketing, and sale of interconnect products based on semiconductor integrated circuits (ICs) in North America, Israel, Europe, and Asia. The companys products primarily focus on computing, storage, and communication applications used in enterprise data centers, computing, and embedded systems. It provides solutions based on InfiniBand, including host channel adapter (HCA), switch and gateway ICs, adapter cards, switch and gateway systems, and software. The company offers adapters to server, storage, communications infrastructure, and embedded systems original equipment manufacturers (OEMs) as ICs or standard card form factors with PCI-X or PCI Express interfaces; and InfiniBand switch ICs, which are used by server, storage, communications infrastructure, and embedded systems OEMs to create switching equipment. Its semiconductor-based interconnect products facilitate data transmission between servers, communications infrastructure equipment, and storage systems. The company sells its products through direct sales force, as well as through a network of domestic and international sales representatives, and independent distributors. Mellanox Technologies was incorporated in 1999 and is headquartered in Yokneam, Israel.

SIMCERE PHARMACEUTICAL-ADR (NYSE:SCR) - Simcere Pharmaceutical Group develops, manufactures, and markets branded generic pharmaceuticals in the Peoples Republic of China. The companys principal branded generic pharmaceuticals include edaravone injection pharmaceutical to treat strokes under the Bicun and Yidasheng brands; amoxicillin capsules, dispersible tablets, granules, and injection under the Zailin brand; generic diclofenac sodium, an anti-inflammatory pain reliever under the Yingtaiqing brand; and sustained release implants for cancer under the Sinofuan brand. Its other branded generic pharmaceutical products comprise generic OTC anti-diarrhea pharmaceuticals under the Biqi brand; amoxicillin and clavulanate potassium tablets, granules, and injection to treat infections under the Anqi brand; cefaclor in dry suspension antibiotics for infections under the Zaike brand; and OTC herbal medicines for coughs under the Simcere Kechuanning brand name. The company also offers pharmaceuticals under various brands in the areas of antibacterial and antiviral, anti-cancer, anti-allergic, anti-osteoporosis, cardiovascular and cerebrovascular, digestive conditions, anti-inflammatory, respiratory system, urinary conditions, and vaccines. As of March 31, 2010, it had 12 product candidates in various stages of development, including treatments for cancer, cerebrovascular diseases, infections, rheumatoid arthritis, nausea, and vomiting associated with chemotherapy. The company manufactures and sells 46 pharmaceuticals and distributes 2 pharmaceuticals that are manufactured by independent third parties under its brand names. It has agreements with Epitomics, Inc. to co-develop and produce humanized RabMAb antibody therapeutics for tumors; and Advenchen to research and develop anti-cancer pharmaceuticals. The company has strategic partnerships with Sun Yat-Sen University Cancer Center and Bristol-Myers Squibb. Simcere Pharmaceutical was founded in 1995 and is headquartered in Nanjing, the Peoples Republic of China.

AMICUS THERAPEUTICS INC (NASDAQ:FOLD) - Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, increase the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its lead product candidate includes Amigal, which is in Phase III development for the treatment of Fabry disease. The company also develops AT2220, which is in Phase I testing for the treatment of Pompe disease. In addition, it develops Plicera for the treatment of Gaucher disease. The company was founded in 2002 and is based in Cranbury, New Jersey.

COMSCORE INC (NASDAQ:SCOR) - comScore, Inc. provides a digital marketing intelligence platform that enables customers to make informed business decisions and implement digital business strategies. Its products and solutions offer customers insights into consumer behavior, including information regarding usage of their online properties and those of their competitors, coupled with information on consumer demographic characteristics, attitudes, lifestyles, and offline behavior. The companys digital marketing intelligence platform comprises proprietary databases and a computational infrastructure that measures, analyzes, and reports on digital activity. It delivers digital marketing intelligence through its comScore Media Metrix product family, comScore Marketing Solutions products, and mobile audience measurement products. The comScore Media Metrix product family provides its subscribers, such as publishers, marketers, advertising agencies, and advertising networks, with intelligence on digital media usage and a measurement of the size, behavior, and characteristics of the audiences for Web sites and advertising networks among home, work, and university Internet populations, as well as offers insights into the effectiveness of online advertising. The comScore Marketing Solutions combine the proprietary information gathered from the comScore panel to deliver digital marketing intelligence, including the measurement of online advertising effectiveness customized for specific industries in the automotive, consumer packaged goods, entertainment, financial services, media, pharmaceutical, retail, technology, telecommunications, and travel sectors. The company serves primarily Internet service providers, investment banks, media and digital agencies, consumer banks, wireless carriers, and credit card issuers principally in the United States, Canada, the United Kingdom, Latin America/Chile, and Japan. comScore, Inc. was founded in 1999 and is headquartered in Reston, Virginia.

KKR & CO LP (NYSE:KKR) - Kohlberg Kravis Roberts & Co. is a private equity and mezzanine investment firm specializing in acquisitions, leveraged buyouts, management buyouts, and mezzanine investments in large cap companies. The firm will consider investments in all industries, with a focus on infrastructure. It seeks a board seat in its portfolio companies. The firms average investment horizon is five years and more. It exits its investments through initial public offerings, secondary offerings, and sales to strategic buyers. The firm holds a controlling interest in its portfolio companies after they go public. Kohlberg Kravis Roberts & Co. was founded in 1976 and is based at New York, New York with additional offices across North America, Europe, and Asia.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641